Post vaccine reactions SINOPHARM COVID-19 in health personnel -Huancayo 2021

• Autores: Poma Salinas , Jenny Giovanna, Garcia Inga , Belinda Olga, Martínez Véliz , Marivel Rosa, Cuadros Ríos , Rosario Eleana
• Formato: artículo
• Fecha de Publicación: 2022
• Institución: Universidad Privada de Huancayo Franklin Roosevelt
• Repositorio: Visionarios en ciencia y tecnología
• Lenguaje: español
• OAI Identifier: oai:revistas.uroosevelt.edu.pe:article/95
• Enlace del recurso: https://revistas.uroosevelt.edu.pe/index.php/VISCT/article/view/95
• Nivel de acceso: acceso abierto

In a global effort to combat the COVID-19 pandemic, vaccination against COVID-19 begins in Peru on February 9, 2021, with priority vaccinating health personnel with the SINOPHARM vaccine. Being unknown what this vaccine would bring with it as reactions, the present work arises. Objective: To identify the most frequent reactions after the vaccine against Covid-19 SINOPHARM in the first and second doses in the Health personnel of Hospital El Carmen, Huancayo 2021. Material and Methods: Basic and descriptive study, the sample made up 284 hospital personnel. Results: 71.1% are between 20 and 49 years old, 80.3% female, 33.4% reacted in the first dose, 48.9% reacted in the second dose, 59.2% tested positive for COVID 19 before being vaccinated, 18.3% tested positive after being vaccinated against COVID 19, 39.4% had no immediate reaction in the first dose, 18.3% had local reactions, 16.2% swelling, 16.2% itching in the vaccination area, 4.9% scleroderma, 4.9% rash; 62.7% had no reaction in the second dose, 10.9% swelling, 9.5% itching in the vaccination area, 7% local reactions, 7% rash, 2.8% scleroderma, 54.5% in the first dose, 90.1% did not react later in the second dose. Conclusions: the most frequent post-vaccine reactions against Covid-19 SINOPHARM in the first and second doses in the Hospital Health personnel were muscle pain, 16.6% in the first dose and 13.5% in the second dose.